Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Immunogenicity of GR2001 in Chinese Healthy Adults

Conditions: Tetanus Interventions: Biological: GR2001; Biological: Placebo; Biological: HTIG; Biological: Tetanus Toxoid Sponsors: Genrix (Shanghai) Biopharmaceutical Co., Ltd. Completed
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials